Sleep disturbances in patients with alzheimer's disease: Epidemiology, pathophysiology and treatment

CNS Drugs

Volumn 15, Issue 10, 2001, Pages 777-796

  Vitiello, M V ^a   Borson, S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DIAZEPAM; DONEPEZIL; GALANTAMINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; RIVASTIGMINE; TACRINE; TRAZODONE;

ALZHEIMER DISEASE; BEHAVIOR; CONFUSION; DELIRIUM; ENVIRONMENTAL FACTOR; EXERCISE; HUMAN; PALLIATIVE THERAPY; PHOTOTHERAPY; PHYSICAL DISEASE; PRIORITY JOURNAL; REVIEW; SLEEP DISORDER;

EID: 0035160782     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200115100-00004     Document Type: Review

References (154)

1. Epidemiology of aging
2. Projections of Alzheimer's disease in the United States and the public health impact of delaying onset
3. Sleep disturbances in community-dwelling patients with Alzheimer's disease
4. Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients
5. Behavioral disturbances of dementia in ambulatory care settings
6. Review and analysis of caregiver burden and nursing home placement
7. Determinants of carer stress in Alzheimer's disease
8. Predictors of institutionalization of cognitively impaired elders: Family help and the timing of placement
9. Predictors of institutionalization for people with dementia living at home with a carer
10. Sleep problems and institutionalization of the elderly
11. Alzheimer disease 1999: A status report
12. Sleep disturbances in patients with mild-stage Alzheimer's disease
13. Changes in the sleep and waking EEGs of nondemented and demented elderly subjects
14. Observed sleep/wakefulness and severity of dementia in an Alzheimers disease special care unit
15. The organization of the human circadian timing system
16. Circadian rhythms and sleep in human aging
17. Output signals of the SCN
18. Efferent signals of the suprachiasmatic nucleus
19. A critical assessment of the melatonin effect on sleep in humans
20. Effective treatment of sleep disturbances in older adults
21. Melatonin as a chronobiotic for circadian insomnia: Clinical observations and animal models
22. Age related changes of the circadian system
23. Circadian rhythms in health aging-effects downstream from the pacemaker
24. Circadian rhythms of agitation in institutionalized patients with Alzheimer's disease
25. Sleep in Alzheimer's disease and other dementing disorders
26. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration
27. A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease
28. Sleep disturbance and Alzheimer's disease: Relationship to behavioral problems
29. Symposium: Cognitive processes and sleep disturbances. Sleep/wake patterns in Alzheimer's disease: Relationships with cognition and function
30. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease
31. Sleep fragmentation in patients from a nursing home
32. Hourly profiles of sleep and wakefulness in severely versus mild-moderately demented nursing home patients
33. Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer disease: A study of 120 patients using the BEHAVE-AD
34. Circadian rest-activity rhythm disturbances in Alzheimer's disease
35. Stage-specific prevalence of behavioral symptoms in Alzheimer's disease in a multi-ethnic community sample
36. Normal aging
37. Assessment and management of sundowning phenomena
38. A description of agitation in a nursing home
39. What is sundowning?
40. Studying disruptive vocalization and contextual factors in the nursing home using computer-assisted real-time observation
41. Travel behavior of nursing home residents perceived as wanderers and nonwanderers
42. Sleep and sundowning in nursing home patients with dementia
43. Sleep electroencephalographic and eye-movement patterns in patients with chronic brain syndrome
44. Sleep in the nursing home
45. Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: Chronobiological perspectives
46. Sleep complaints among elderly persons: An epidemiologic study of three communities
47. Incidence and remission of insomnia among elderly adults in a biracial cohort
48. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group
49. Sleep problems in the community elderly as predictors of death and nursing home placement
50. Management of insomnia in hospitalized patients
51. Rationale and design of the Canadian continuous positive airway pressure trial for congestive heart failure patients with central sleep apnea - CANPAP
52. Nocturnal enuresis in community-dwelling older adults
53. Interactions of sleep and Parkinson's disease
54. Diagnosis and management of parasomnias
55. Sleep disorder related to Parkinson's disease
56. Gastrointestinal illness and sleep
57. Nocturia: A rarely recognized symptom of sleep apnea and other occult sleep disorders
58. Drugs that disturb sleep and wakefulness
59. Drug-induced sleep disturbances: Focus on nonpsychotropic medications
60. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults. The Cardiovascular Health Study
61. Sleep complaints in community-dwelling older persons: Prevalence, associated factors, and reported causes
62. Epidemiological study on insomnia in the general population
63. Depression as a confounding variable in the estimation of habitual sleep time
64. Does sleep disturbance predict depression in elderly people? A study in inner London
65. Prevalence and correlates of dysthymia and major depression in Alzheimer's disease
66. Mental and behavioral disturbances in dementia: Findings from the Cache County study on memory in aging
67. Delirium risk factors in elderly hospitalized patients
68. Prevention of delirium in hospitalized older patients: Risk factors and targeted intervention strategies
69. Drug-induced cognitive impairment in the elderly
70. Delirium among elderly persons admitted to a psychiatric hospital: Clinical course during the acute stage and one year follow-up
71. Sleep-disordered breathing in community-dwelling elderly
72. The treatment of restless legs syndrome and periodic limb movement disorder: An American Academy of Sleep Medicine review
73. Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment
74. Sleep in the dementing disorders
75. Periodic limb movements in sleep in community-dwelling elderly
76. Restless legs syndrome: A disease in search of identity
77. Clinical significance of sleep-disordered breathing in Alzheimer's disease: Preliminary data
78. Sleep apnea in Alzheimer's disease
79. Dementia in institutionalized elderly: Relation to sleep apnea
80. Is sleep apnea a cause of reversible dementia in old age?
81. Sleep disordered breathing in the elderly
82. Pharmacologic management of Alzheimers disease: A guide for clinicians
83. Gastro-oesophageal reflux treatment for asthma in adults and children
84. Possible involvement of central cholinergic-serotonergic interaction in natural sleep
85. Effect of tetrahydroaminoacridine on sleep in healthy subjects
86. Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in man
87. Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep
88. THA does not affect sleep or EEG spectral power in Alzheimer's disease
89. Improvement of sleep and behavior by methylphenidate in Alzheimer's disease
90. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial
91. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities
92. Antipsychotics treatment of psychosis and agitation in the elderly
93. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease
94. Diagnosis and management of sleep apnea syndrome
95. Surgical treatment for obstructive sleep apnoea
96. Practice parameters for the nonpharmacologic treatment of chronic insomnia: An American Academy of Sleep Medicine report
97. Iron, brain and restless legs syndrome
98. Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome
99. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine
100. Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: A 2-year follow-up
101. Incidence and preventability of adverse drug events in nursing homes
102. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes
103. Psychotropic medications in incontinent nursing home residents: Association with sleep and bed mobility
104. Differences in self-reported sleep complaints in elderly persons living in the community who do or do not take sleep medication
105. The impact of sedative-hypnotic use on sleep symptoms in elderly nursing home residents
106. Insomnia and psychotropic drug consumption
107. Non-benzodiazepines for the treatment of insomnia
108. Zolpidem for dementia-related insomnia and nighttime wandering
109. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography
110. Triazolam in Alzheimer's disease: Pilot study on sleep and memory effects
111. Prescribing of anticholinergic TCAs in nursing homes
112. Self-care capacity and anticholinergic drug levels in nursing home patients
113. Entrainment of free-running circadian rhythms by melatonin in blind people
114. Use of melatonin for sleep and circadian rhythm disorders
115. Melatonin and clinical application
116. Melatonin for treatment of sundowning in elderly persons with dementia - A preliminary study
117. Effects of melatonin in two individuals with Alzheimer's disease
118. Effect of melatonin in selected populations of sleep-disturbed patients
119. The treatment of sleep disorders in older people
120. Chronic hypnotic use: Deadly risks, doubtful benefit
121. Hypnotic medication in the treatment of chronic insomnia: Non nocere! Doesn't anyone care?
122. Non nocere if you really care: Commentary on 'Hypnotic medication in the treatment of chronic insomnia' by Dr. Kramer
123. 'Non nocere, but we both care': Commentary on 'Non nocere of you really care' by Dr. Kripke, MD
124. Rational pharmacotherapy for insomnia: Time for a new paradigm
125. Behavioral and pharmacological therapies for late-life insomnia: A randomized controlled trial
126. Sleep disturbances in the demented elderly: Treatment in ambulatory care
127. The nursing home at night: Effects of an intervention on noise, light, and sleep
128. Individualizing night-time incontinence care in nursing home residents
129. Nighttime urinary incontinence and sleep disruption among nursing home residents
130. Approach to sleep disorders in the nursing home setting
131. Adapting living environments for persons with Alzheimer's disease
132. Effects of an environmental manipulation emphasizing client-centred care on agitation and sleep in dementia sufferers in a nursing home
133. Multiple occupancy versus private rooms on dementia care units
134. Circadian rhythm disorders in sleep-waking and body temperature in elderly patients with dementia and their treatment
135. Low illumination experienced by San Diego adults: Association with atypical depressive symptoms
136. A comparison of the strength of external zeitgebers in young and older adults
137. Changes in circadian rhythms and sleep quality with aging: Mechanisms and interventions
138. Exposure to light in healthy elderly subjects and Alzheimer's patients
139. Variations in circadian rhythms of activity, sleep and light exposure related to dementia in nursing-home patients
140. Treatment of sleep disturbance in Alzheimer's disease
141. Phototherapy for patients with Alzheimer disease with disturbed sleep patterns: Results of a community-based pilot study
142. Moderate-intensity exercise and self-rated quality of sleep in older adults: A randomized controlled trial
143. Sleep, sleep deprivation, and daytime activities
144. Elder rehab: A student-supervised exercise program for Alzheimer's patients
145. The feasibility of conducting strength and flexibility programs for elderly nursing home residents with dementia
146. A randomized outcome evaluation of group exercise programs in long-term care institutions
147. Effects of physical therapy on functional status of nursing home residents
148. Exercise and activity level in Alzheimer's disease: A potential treatment focus
149. A randomized trial of a combined physical activity and environmental intervention in nursing home residents: Do sleep and agitation improve?
150. Daily social and physical activity increases slow-wave sleep and daytime neuropsychological performance in the elderly
151. Stress reduction for family caregivers: Effects of adult day care use